Toolkit for COVID-19 Convalescent Plasma

This frequently updated toolkit includes tabulated information about changes to the Emergency Use Authorization (EUA) for COVID-19 Convalescent Plasma (CCP); detailed information about blood donor referrals after COVID-19 vaccination or CCP infusion; flowcharts on investigational and EUA use, collection, and testing and labeling of CCP, and a sample flowchart for updating a deferral policy for vaccines to help evaluate donor risk following vaccination.
Rate: Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.